G1_RPMI_modified_Blood_M1T1_5448_vs_G2_Pooled_sera_Blood_M1T1_5448

Profile details

Identifier: MTBLS2324_0002_00000001
Linked study: MTBLS2324 — Bioplatforms Australia: Antibiotic Resistant Sepsis Pathogens Framework Initiative (Streptococcus pyogenes assays)
Comparison: RPMI_modified_Blood_M1T1_5448 vs Pooled_sera_Blood_M1T1_5448
Group A: Samples from Streptococcus pyogenes M1T1 clone 5448 grown in RPMI modified media from blood.. Represents a specific condition of Streptococcus pyogenes for comparative analysis.
Group B: Samples from Streptococcus pyogenes M1T1 clone 5448 grown in pooled sera from blood.. Represents a specific condition of Streptococcus pyogenes for comparative analysis.
Total features tested: 121
Significant features: 52
p-value threshold: 0.05
Ratio threshold (upper): 1.5
Ratio threshold (lower): 1/1.5
Date created: 2025-09-26 00:00:00

Metabolite ID (InChI Key)	Name	Direction	Ratio	p-value
HSCJRCZFDFQWRP-LNYDKVEPSA-N	UDP-D-galactopyranose	up	1e+06	5.91e-05
ZDXPYRJPNDTMRX-GSVOUGTGSA-N	(2<i>R</i>)-5-amino-2-ammonio-5-oxopentanoate	up	133	8.91e-06
XOAAWQZATWQOTB-UHFFFAOYSA-N	2-ammonioethanesulfonate	down	0.04541	1.15e-07
LFTYTUAZOPRMMI-CFRASDGPSA-N	(2R,3R,4R,5S,6R)-3-(acetylamino)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl [(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl dihydrogen diphosphate (non-preferred name)	up	58.81	2.58e-05
DTBNBXWJWCWCIK-UHFFFAOYSA-N	PEP	up	16.6	4.85e-05
DQAKJEWZWDQURW-UHFFFAOYSA-N	—	up	9.201	3.88e-06
OSJPPGNTCRNQQC-UHFFFAOYSA-N	Glycerate 3-phosphate	up	105	0.00307
ROHFNLRQFUQHCH-YFKPBYRVSA-N	<small>L</small>-Leuzin	up	8.223	3.93e-06
RWQNBRDOKXIBIV-UHFFFAOYSA-N	5-Methyluracil	up	7.726	9.9e-06
GHOKWGTUZJEAQD-UHFFFAOYSA-N	<em>N</em>-(2,4-dihydroxy-3,3-dimethylbutanoyl)-β-alanine	up	13.41	0.000132